Stockreport

FDA accepts ADMA Bio's refiled marketing application for RI-002, action date April 2, 2019 [Seeking Alpha]

ADMA Biologics Inc  (ADMA) 
Last adma biologics inc earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.admabiologics.com
PDF The FDA has accepted for review ADMA Biologics' (NASDAQ: ADMA ) resubmitted BLA seeking approval for lead candidate RI-002 for the treatment of patients with pr [Read more]